Search

everythinglearnresearchcommunity

for

Search:↓

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

SPRY1 deficiency in skin cells causes stem cells to move to the skin surface, leading to increased pigmentation.

The document suggests a clinical trial to accurately determine if PRP is an effective treatment for a common type of hair loss in men.

PRP, exosomes, and physical therapies show promise for hair and tissue repair, but need more research for optimization.

Different sPLA2 enzymes affect immunity, skin and hair health, reproduction, and may be potential targets for therapy.

Using old drugs for new uses can help treat rare immune deficiencies.

PRP shows promise for hair loss treatment, but needs standardized preparation and composition.

Neurosteroid production in the brain may delay seizure onset.

Researchers found that most genes affecting drug responses are not fully covered by commercial SNP chips, suggesting the need for more comprehensive tools to optimize drug selection based on genetics.

A new HRAS gene variant may cause a range of symptoms including intellectual disability and psychiatric issues.

More research is needed to confirm PRP's effectiveness for scarring alopecia.

The PON1 192R gene variant is linked to a higher risk of psoriasis and heart disease in Western Mexico.

The Spanish version of the WAA-QoL questionnaire is reliable and valid for assessing quality of life in women with hair loss.

Cutaneous lupus erythematosus greatly reduces patients' quality of life.

Accurate diagnosis of progressive supranuclear palsy requires thorough neurological assessments and MRI.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.

The "exposure–crossover design" helps assess individual changes in risk after events like car crashes.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

No link found between specific genes and female pattern hair loss.

Platelet-rich plasma (PRP) treatments are not effective.

The models accurately predicted urticaria in Ukrainian women but struggled to differentiate between mild and severe cases based on body structure.

Powered exoskeleton training improves body perception and quality of life in spinal cord injury patients.

The MBTPS2 gene variant c.970+5G>A is a common mutation causing IFAP syndrome.

Some patients fail bladder function tests due to lower flow rates and higher remaining urine volumes, but the exact reasons for failure are unclear.

Researchers created a reliable method to measure dexpanthenol and resorcinol in hair products.

5α-reductase inhibitors lower overall prostate cancer risk but not high-grade cancer risk; longer-term screening and new treatments show promise.

The Brazilian version of the Alopecia Areata Quality of Life Index is reliable for assessing patients' quality of life.

Drospirenone is a unique progestin with anti-water retention and potential blood pressure benefits, used in birth control and hormone therapy.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Finasteride dosages should be adjusted based on CYP3A5 genotype and liver function to avoid side effects.